The hepatic arterial infusion pump, a hockey puck-sized device that essentially bathes liver tumors in floxuridine for about 2 weeks, is not a new technology.

Medtronic and the Mann Foundation go way back: In 2001, the Mann-founded insulin pump and glucose monitor maker MiniMed sold to Medtronic for more than $3 billion, becoming the basis of Medtronic ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New automated insulin delivery pumps have significantly improved diabetes care, ...

Key Results Cutaneous symptoms at pump sites were common, with 93.3% of participants reporting itching and 76.7% reporting skin redness. The OCT angiography microvascular maps showed increased ...

Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus ...